Literature DB >> 11206842

Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems.

K Denda-Nagai1, K Fujita, M Fujime, S Nakatsugawa, T Ishigaki, T Irimura.   

Abstract

A correlation between MUC1 expression in renal cell carcinomas (RCCs) and the clinical stages was previously demonstrated. To assess whether MUC1 expression is causally related to malignant tumor behavior, MUC1 cDNA was stably transfected into a renal carcinoma cell line SN12C that expresses trace levels of MUC1. MUC1 with sialylated carbohydrate chains was detected on the surface of transfected cells in two independent experiments. There was no correlation between MUC1 expression and in vitro growth and motility. In vivo growth of the transfectants at the site of orthotopic transplantation in nude mice was slower than mock transfected cells. Therefore, MUC1 alone did not seem to confer a malignant phenotype to RCCs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11206842     DOI: 10.1023/a:1026508402526

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  15 in total

1.  Increased invasiveness of MUC1 and cDNA-transfected human gastric cancer MKN74 cells.

Authors:  T Suwa; Y Hinoda; Y Makiguchi; T Takahashi; F Itoh; M Adachi; M Hareyama; K Imai
Journal:  Int J Cancer       Date:  1998-05-04       Impact factor: 7.396

Review 2.  Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.

Authors:  T Irimura; K Denda; S i Iida; H Takeuchi; K Kato
Journal:  J Biochem       Date:  1999-12       Impact factor: 3.387

3.  Suppression of cellular aggregation by high levels of episialin.

Authors:  M J Ligtenberg; F Buijs; H L Vos; J Hilkens
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

Review 4.  Expression of mucin antigens in human cancers and its relationship with malignancy potential.

Authors:  S Yonezawa; E Sato
Journal:  Pathol Int       Date:  1997-12       Impact factor: 2.534

5.  Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.

Authors:  Y Dong; M D Walsh; M C Cummings; R G Wright; S K Khoo; P G Parsons; M A McGuckin
Journal:  J Pathol       Date:  1997-11       Impact factor: 7.996

6.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

Authors:  E van de Wiel-van Kemenade; M J Ligtenberg; A J de Boer; F Buijs; H L Vos; C J Melief; J Hilkens; C G Figdor
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

7.  Delayed mammary tumor progression in Muc-1 null mice.

Authors:  A P Spicer; G J Rowse; T K Lidner; S J Gendler
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

8.  A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

Authors:  J Wesseling; S W van der Valk; J Hilkens
Journal:  Mol Biol Cell       Date:  1996-04       Impact factor: 4.138

9.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

10.  A novel monoclonal antibody specific for sialylated MUC1 mucin.

Authors:  M Yamamoto; V P Bhavanandan; S Nakamori; T Irimura
Journal:  Jpn J Cancer Res       Date:  1996-05
View more
  2 in total

Review 1.  MUC1 in carcinoma-host interactions.

Authors:  K Denda-Nagai; T Irimura
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 3.009

Review 2.  Cancer therapy using tumor-associated antigens to reduce side effects.

Authors:  David Siu
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 5.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.